930
J. Rujirawanich et al. / Carbohydrate Research 346 (2011) 927–932
J = 3.6 Hz, 1H), 4.85 (CH-2, dd, J = 8.9 Hz, 1H), 4.66 (–OCH2Ar, d,
J = 11.8 Hz, 1H), 4.65 (–OCH2Ar, d, J = 12.4 Hz, 1H), 4.46 (–OCH2Ar,
d, J = 11.8 Hz, 1H), 4.44 (–OCH2Ar, d, J = 12.3 Hz, 1H), 3.96–4.02
(CH-3, m, 1H), 3.71 (CH-4, dd, J = 3.5, 2.1 Hz, 1H), 3.75 (CH2-5,
dd, J = 12.6, 1.9 Hz, 1H), 3.68 (CH2-5, dd, J = 12.6, 1.1 Hz, 1H), 2.36
(OH, br d, J = 10.3 Hz, 1H), 2.01 (–OCOCH3, s, 3H); 13C NMR
(100 MHz, CDCl3): d 169.4, 133.9, 131.6, 131.6, 128.8, 128.8,
127.4, 110.3, 85.6, 75.4, 71.9, 71.1, 64.0, 27.5, 26.2, 20.8.
3.6. Benzyl exo/endo-3,4-O-benzylidene-b-
(6exo and 6endo)
L-arabinopyranosides
To a solution of 1 (100 mg, 0.42 mmol) in dry N,N-dimethyl-
formamide (1.5 mL) were added -dimethoxytoluene (0.09 mL,
a,a
0.67 mmol) and para-toluenesulfonic acid (0.8 mg, 0.004 mmol).
The reaction mixture was stirred at room temperature for 24 h. Tri-
ethylamine was added before concentration and the syrup which
was dissolved in EtOAc was extracted with saturated aqueous
NaHCO3, water, dried over anhydrous Na2SO4 and concentrated
in vacuo. The residue was purified by flash column chromatogra-
phy (EtOAc/hexane, 1:4) to afford 6exo and 6endo as a white solid
3.4. Benzyl 2-O-acetyl-b-L-arabinose (4)
A solution of 3 (312 mg, 0.96 mmol) in 70% aqueous acetic acid
(4.7 mL) was stirred at 70 °C for 1 h and then concentrated in va-
cuo, and the traces of acetic acid and water were removed by co-
evaporation with toluene several times. The residue was purified
by flash column chromatography (EtOAc/hexane, 7:3) to afford 4
as a white solid (264 mg, 96%): mp 98–100 °C (hexane/Et2O) (lit.10
in 4:5 ratio (106 mg, 77.2%); ½a D20
ꢂ
+139 (c 0.21, CH2Cl2); IR (NaCl)
mmax 3436 (OH), 1091, 1067, 1022 (C–O–C) cmꢁ1
;
1H NMR
(400 MHz, CDCl3) d 7.48–7.53 (ArH, m, 16H), 7.43–7.44 (ArH, m,
2H), 7.27–7.40 (ArH, m, 2H), 6.16 (CH-6-exo, s, 1H), 5.85 (CH-6-
endo, s, 1H), 4.96 (CH-1-exo, d, J = 3.7 Hz, 1H), 4.91 (CH-1-endo,
d, J = 3.6 Hz, 1H), 4.53 (–OCH2Ar-exo, d, J = 11.80 Hz, 2H), 4.75 (–
OCH2Ar-exo, d, J = 11.8 Hz, 2H), 4.54 (–OCH2Ar-endo, d,
J = 11.8 Hz, 2H), 4.78 (–OCH2Ar-endo, d, J = 11.7 Hz, 2H), 4.41
(CH-2-exo, dd, J = 7.1, 5.6 Hz, 1H), 4.33 (CH-2-endo, dd, J = 6.4,
6.4 Hz, 1H), 4.14–4.16 (CH-3-exo, m, 1H), 4.23–4.25 (CH-3-endo,
m, 1H), 3.89 (CH-4-exo, dd, J = 7.2, 3.7 Hz, 1H), 3.86 (CH-4-endo,
dd, J = 6.2, 3.6 Hz, 1H), 3.93 (CH2-5-exo, dd, J = 13.3, 2.5 Hz, 1H),
4.04 (CH2-5-exo, dd, J = 13.3, 2.4 Hz, 1H), 3.98 (CH2-5-endo, dd,
J = 13.2, 1.0 Hz, 1H), 4.00 (CH2-5-endo, d, J = 13.2, 1.6 Hz, 1H); 13C
NMR (100 MHz, CDCl3) d 136.8, 136.9, 137.0, 138.9, 129.6, 129.4,
129.3, 128.9, 128.8, 128.5, 128.5, 128.5, 128.4, 127.9, 126.6,
125.9, 103.8, 102.8, 97.0, 96.5, 76.9, 75.7, 73.0, 74.7, 69.6, 69.6,
67.9, 69.7, 59.4, 59.8; ESIMS: m/z calcd for C19H20O5Na [M+Na]+
351.1208; found 351.1209.
101 °C); ½a 2D0
ꢂ
+230 (c 0.20, CH2Cl2); IR (NaCl) mmax 3428 (O–H),
1732 (C@O), 1372 (C–H), 1244 (C–O–C), 1059 (C–O–C) cmꢁ1
;
1H
NMR (400 MHz, CDCl3) d 7.20–7.31 (ArH, m, 5H), 4.99 (CH-1, d,
J = 3.7 Hz, 1H), 4.94 (CH-2, dd, J = 3.7, 10.0 Hz, 1H), 4.66 and 4.44
(–OCH2Ar, J = 12.3 Hz, 2H), 4.01 (CH-3, dd, J = 3.5, 10.0 Hz, 1H),
3.93–3.94 (CH-4, m, 1H), 3.85 (CH2-5, dd, J = 1.4, 12.6 Hz, 1H),
3.68 (CH2-5, dd, J = 2.0, 12.6 Hz, 1H), 2.03 (–OCOCH3, s, 3H), 2.95
(–OH, br s, 2H); 13C NMR (100 MHz, CDCl3) d 170.4, 137.1, 128.4,
127.9, 127.6, 95.2, 73.5, 72.8, 72.2, 69.4, 58.8, 20.9; ESIMS: m/z
calcd for C14H18O6Na [M+Na]+ 305.1001; found: 305.1005.
3.5. Benzyl 2-O-acetyl-exo/endo-3,4-O-benzylidene-b-
arabinopyranosides (5exo/5endo)
L-
To a solution of 4 (200 mg, 0.71 mmol) in dry acetonitrile
(2.5 mL) were added -dimethoxytoluene (0.16 mL, 1.13 mmol)
a,a
3.7. Benzyl 2-O-benzyl-(7exo) and endo-3,4-O-benzylidene-b-
arabinopyranosides (7endo)
L-
and para-toluenesulfonic acid (1.4 mg, 0.007 mmol). The reaction
mixture was stirred at room temperature for 6 h. Triethylamine
was added before concentration and the syrup which was dis-
solved in EtOAc was extracted with saturated aqueous NaHCO3,
water, dried over anhydrous Na2SO4, and concentrated in vacuo.
The residue was purified by flash column chromatography
(EtOAc/hexane, 3:17 to afford 5exo as a yellow syrup (42.0 mg,
16%) and 5endo as a yellow syrup (168 mg, 64%) and starting mate-
rial (10.0 mg, 5%).
A mixture of 6exo and 6endo (100 mg, 0.30 mmol) were treated
with benzyl bromide (1.1 mL, 9.14 mmol) in the presence of KOH
(205 mg, 3.65 mmol) for 5 h at 50 °C. The reaction mixture was di-
luted with dichloromethane and filtered, and benzyl bromide was
removed by stream distillation. The oily residue was purified by
flash column chromatography (EtOAc/hexane, 1:9) to afford 7exo
as a yellow syrup (44.4 mg, 35%) and 7endo as a yellow syrup
(54.3 mg, 41%).
Compound 5exo: ½a D20
ꢂ
+177 (c 0.30, CH2Cl2); IR (NaCl)
m
max 1749
(C@O), 1272 (C–O–C), 1089, 1026 (C–O–C) cmꢁ1
;
1H NMR
Compound 7exo: ½a D20
ꢂ
+134 (c 0.45, CH2Cl2); IR (NaCl) mmax 1274
(400 MHz, CDCl3) d 7.41–7.44 (ArH, m, 2H), 7.21–7.38 (ArH, m,
8H), 6.12 (CH-6, s, 1H), 5.01 (CH-1, d, J = 4.0 Hz, 1H), 5.00 (CH-2,
dd, J = 11.8, 3.96 Hz, 1H), 4.60 (CH-3, dd, J = 7.7, 5.3 Hz, 1H), 4.67
(–OCH2Ar, d, J = 12.3 Hz, 1H), 4.44 (–OCH2Ar, d, J = 12.3 Hz, 1H),
4.18 (CH-4, dd, J = 5.6, 2.5 Hz, 1H), 3.92 (CH2-5, dd, J = 13.4,
2.6 Hz, 1H), 4.00 (CH2-5, d, J = 13.5 Hz, 1H), 2.03 (–OCOCH3, s,
3H); 13C NMR (100 MHz, CDCl3) d 170.5, 137.0, 138.7, 129.6,
128.6, 128.5, 128.5, 127.6, 126.8, 126.8, 126.8, 126.1, 126.1,
102.8, 95.1, 73.4, 74.1, 69.5, 69.6, 58.8, 20.9; ESIMS: m/z calcd for
(C–O), 1099, 1045, 1019 (C–O–C) cmꢁ1; 1H NMR (400 MHz, CDCl3)
d
7.18–7.38 (ArH, m, 15H), 5.95 (CH-6, s, 1H), 4.88 (CH-1, d,
J = 3.4 Hz, 1H), 4.71 (–OCH2Ar, d, J = 12.5 Hz, 1H), 4.64 (–OCH2Ar,
d, J = 11.56 Hz, 1H), 4.63 (–OCH2Ar, d, J = 12.2 Hz, 1H), 4.62 (CH-3,
dd, J = 8.0, 5.4 Hz, 1H), 4.48 (–OCH2Ar, d, J = 12.3 Hz, 1H), 4.13
(CH-4, m, 1H), 3.92 (CH2-5, dd, J = 13.4, 1.0 Hz, 1H), 3.88 (CH2-5,
dd, J = 13.3, 2.4 Hz, 1H), 3.62 (CH-2, dd, J = 8.0, 3.5 Hz, 1H). 13C
NMR (100 MHz, CDCl3)
d 139.0, 138.1, 137.1, 129.0, 128.4,
128.4, 128.4, 128.3, 128.3, 128.3, 127.9, 127.8, 127.8,
127.8, 127.7, 126.1, 102.6, 95.8, 76.6, 73.8, 73.4, 72.2, 69.3, 58.9;
C
21H22O6Na [M+Na]+ 393.1314; found: 393.1310.
Compound 5endo: ½a D20
ꢂ
+206 (c 0.30, CH2Cl2); IR (NaCl) mmax
ESIMS: m/z calcd for
C
26H26O5Na [M+Na]+ 441.1678; found
1736 (C@O), 1233 (C–O–C), 1067 (C–O–C) cmꢁ1
;
1H NMR
441.1680.
(400 MHz, CDCl3) d 7.41–7.44 (ArH, m, 2H), 7.21–7.38 (ArH, m,
8H), 5.82 (CH-6, s, 1H), 4.98 (CH-1, d, J = 3.5 Hz, 1H), 4.90 (CH-2,
dd, J = 7.8, 3.5 Hz, 1H), 4.46 (CH-3, dd, J = 7.6, 6.4 Hz, 1H), 4.67 (–
OCH2Ar, d, J = 12.3 Hz, 1H), 4.44 (–OCH2Ar, d, J = 12.3 Hz, 1H),
4.25 (CH-4, dd, J = 6.1, 2.2 Hz, 1H), 4.00 (CH2-5, dd, J = 13.5,
3.0 Hz, 1H), 4.08 (CH2-5, d, J = 13.2 Hz, 1H), 1.99 (–OCOCH3, s,
3H); 13C NMR (100 MHz, CDCl3) d 170.3, 136.6, 137.0, 129.1,
128.5, 128.5, 127.6, 127.6, 126.8, 126.8, 126.8, 126.1, 126.1,
104.4, 95.0, 75.8, 72.6, 72.7, 69.6, 58.7, 20.9; ESIMS: m/z calcd for
Compound 7endo: ½a D20
ꢂ
+170 (c 0.24, CH2Cl2); IR (NaCl) mmax
1272 (C–O), 1090, 1068, 1022 (C–O–C) cmꢁ1 1H NMR (400 MHz,
;
CDCl3) d 7.10–7.37 (ArH, m, 15H), 5.84 (CH-6, s, 1H), 4.77 (CH-1,
d, J = 3.4 Hz, 1H), 4.68 (–OCH2Ar, d, J = 12.3 Hz, 1H), 4.59 (–OCH2Ar,
d, J = 12.3 Hz, 1H), 4.47 (–OCH2Ar, d, J = 12.6 Hz, 1H), 4.46 (–
OCH2Ar, d, J = 12.3 Hz, 1H), 4.44 (CH-3, dd, J = 6.0, 1.9 Hz, 1H),
4.23 (CH-4, ddd, J = 6.2, 2.8, 1.3 Hz, 1H), 4.01 (CH2-5, dd, J = 13.4,
1.2 Hz, 1H), 3.96 (CH2-5, dd, J = 13.3, 3.0 Hz, 1H), 3.52 (CH-2, dd,
J = 7.5, 3.4 Hz, 1H). 13C NMR (100 MHz, CDCl3) d 138.1, 137.5,
137.2, 129.2, 128.4, 128.4, 128.4, 128.3, 128.3, 128.2, 127.9,
C
21H22O6Na [M+Na]+ 393.1314; found 393.1310.